SSG
YDESW

Summit Securities Group’s YD Bio Ltd Warrants YDESW Stock Holding History

Summit Securities Group’s Portfolio YDESW Stock Details YDESW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1
Closed -$1 – 1415
2026
Q1 		$1 Hold
1
– – ﹤0.01% 1015
2025
Q4 		$1 Buy
+1
New +$1 ﹤0.01% 986

Other funds holding YDESW

CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $120M AUM 63.01% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
TNA
True North Advisors Dallas, Texas $1.05B AUM 22.99% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

Summit Securities Group's YDESW Position: Q2 2026 in Review

Summit Securities Group sold out of YD Bio Ltd Warrants (YDESW) in Q2 2026, closing a stake of 1 share — an estimated $1 sold.

Summit Securities Group first reported a position in YDESW in Q4 2025 and held it in 2 quarters. The position peaked at $1 in Q1 2026. 8 funds tracked by Wall St. Rank hold YDESW as of Q2 2026.

  • Summit Securities Group reported no remaining YD Bio Ltd Warrants position as of Q2 2026 after selling out during the quarter.
  • Summit Securities Group sold 1 YD Bio Ltd Warrants share in Q2 2026, an estimated $1.
  • Summit Securities Group first reported a position in YD Bio Ltd Warrants in Q4 2025 and held it in 2 quarters.
  • Summit Securities Group's YD Bio Ltd Warrants position peaked at $1 in Q1 2026.
  • 8 funds tracked by Wall St. Rank held YD Bio Ltd Warrants as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.